المؤلفون: Pauline du Rusquec, Cyriac Blonz, Jean Sebastien Frenel, Mario Campone

المصدر: Therapeutic Advances in Medical Oncology, Vol 12 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-8359

URL الوصول: https://doaj.org/article/8b1b051acf4145d58d96075668e7bba1

المؤلفون: Karim Chikh, Charlotte Cuerq, Marie Valero, Olivier Colomban, Aude-Marie Savoye, Dominique Berton, Laëtitia Stefani, Michel Fabbro, Cyriac Blonz, Olivier Tredan, Margot Noblecourt, Oana Cojocarasu, Delphine Mollon-Grange, Fabrice Barlesi, Eric Pujade-Lauraine, Gilles Freyer, Benoit You, Hubert Vidal, Claire Falandry

المصدر: Ovarian cancer.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e451b1834ac74b43463d7fd9ca1d9ac8
https://doi.org/10.1136/ijgc-2022-esgo.630

المؤلفون: Olivier Colomban, Emmanuelle Bourbouloux, Marie-Ange Mouret-Renier, Domenica Lorusso, Cyriac Blonz, Aude Marie Savoye, Gilles Freyer, Margot Noblecourt, Michel Gatineau, Laëtitia Stefani, Laurence Gladieff, Florence Joly, Laurence Venat-Bouvet, Delphine Mollon-Grange, Ulla Peen, Lucia Borgato, Eric Pujade-Lauraine, Benoit You, Claire Falandry

المصدر: Ovarian cancer.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b9bc45f7675c47faa6ed49040eef14e5
https://doi.org/10.1136/ijgc-2022-esgo.680

المؤلفون: Marie Robert, Mario Campone, Anne Patsouris, Cyriac Blonz, Paule Augereau, Jean-Sebastien Frenel, Marion Bertho

المساهمون: Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Stress Adaptation and Tumor Escape in Breast Cancer (CRCINA-ÉQUIPE 8), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Bernardo, Elizabeth

المصدر: Expert Opinion on Drug Metabolism and Toxicology
Expert Opinion on Drug Metabolism and Toxicology, Taylor & Francis, 2021, 17 (2), pp.139-152. ⟨10.1080/17425255.2021.1844662⟩
Expert Opinion on Drug Metabolism and Toxicology, 2021, 17 (2), pp.139-152. ⟨10.1080/17425255.2021.1844662⟩

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Receptor, ErbB-2, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Disease, Toxicology, PIK3CA mutation, 030226 pharmacology & pharmacy, Alpelisib, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Animals, Humans, Endocrine system, Neoplasm Metastasis, PI3K/AKT/mTOR pathway, Phosphoinositide-3 Kinase Inhibitors, Pharmacology, Fulvestrant, business.industry, Cancer, General Medicine, PI3K inhibitors, medicine.disease, Metastatic breast cancer, 3. Good health, Thiazoles, Regimen, 030220 oncology & carcinogenesis, Mutation, Female, metastatic breast cancer, business, medicine.drug, Hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd7bcfc615a5d8d162f2b328824147a6
https://www.hal.inserm.fr/inserm-03495760

المؤلفون: Catherine Guerin, Mario Campone, Nicole Andrieux, Ludovic Doucet, Cyriac Blonz, Marie Robert, Camille Moreau-Bachelard, Emmanuelle Bourbouloux, Carole Gourmelon, Dominique Berton, Jean-Sebastien Frenel

المصدر: Journal of Clinical Oncology. 38:589-589

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Retrospective cohort study, Disease, medicine.disease, Breast cancer, Trastuzumab, Internal medicine, Long term outcomes, Medicine, business, Pathological, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::03178d173eabe2585b07d55025fe2106
https://doi.org/10.1200/jco.2020.38.15_suppl.589